The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Cascadian Therapeutics
Stock and Other Ownership Interests - Cascadian Therapeutics

Clinical benefit of tucatinib after isolated brain progression: A retrospective pooled analysis of tucatinib phase 1b studies in HER2+ breast cancer.
 
Rashmi Krishna Murthy
Consulting or Advisory Role - Daiichi Sankyo; Genentech
Research Funding - Daiichi Sankyo; Genentech/Roche; Merrimack (Inst); Oncothyreon (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Oncothyreon
 
Erika Paige Hamilton
Consulting or Advisory Role - Cascadian Therapeutics (Inst); Flatiron Health; Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Curis (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); Fujifilm (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Hutchison MediPharma (Inst); Immunomedics (Inst); Kadmon (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); Mallinckrodt (Inst); MedImmune (Inst); Medivation (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Novartis (Inst); Nucana (Inst); OncoMed (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Rgenix (Inst); Stem CentRx (Inst); Syndax (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); TetraLogic Pharmaceuticals (Inst); Verastem (Inst); Zymeworks (Inst)
 
Cristiano Ferrario
Honoraria - Amgen; Astellas Oncology; Bayer; Pfizer
Consulting or Advisory Role - Janssen; Novartis; Roche
Research Funding - Abbvie (Inst); Alethia Biotherapeutics (Inst); Astellas Oncology (Inst); AstraZeneca (Inst); Cascadian Therapeutics (Inst); Celldex (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis
 
Nathalie Aucoin
Consulting or Advisory Role - Abbvie; Amgen; Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; Lundbeck; Merck; Novartis; Roche; Shire
Research Funding - Cascadian Therapeutics (Inst); EMD Serono (Inst); Merck (Inst); Novartis (Inst)
 
Carla Isadora Falkson
Honoraria - bioTheranostics
Consulting or Advisory Role - bioTheranostics
Research Funding - bioTheranostics (Inst); Cascadian Therapeutics (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - bioTheranostics
 
Marc C. Chamberlain
No Relationships to Disclose
 
Todd Gray
Employment - Cascadian Therapeutics
Stock and Other Ownership Interests - Cascadian Therapeutics
 
Virginia F. Borges
Research Funding - Abbott/AbbVie (Inst); Advaxis (Inst); Galena Biopharma (Inst); Incyte (Inst); Merrimack (Inst); Oncothyreon (Inst)